A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

NCT06619561 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Graft-Versus-Host Disease (cGVHD)

Interventions

DRUG: Vimseltinib

Sponsor

Deciphera Pharmaceuticals, LLC